Skip to content

Clinical trials

Observational Emphysema trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Emphysema Phase: Observational Clear all

117 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20021
20031
20047
20053
20063
20078
20081
20097
20104
20115
20124
20132
20147
20153
20166
20176
20185
20192
20203
20218
20225
20236
20244
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59
Recruiting21
Unknown status15
Terminated8
Active, not recruiting7
Withdrawn3
Enrolling by invitation2
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Pittsburgh7
Imperial College London6
University Medical Center Groningen6
National Heart, Lung, and Blood Institute (NHLBI)5
Columbia University4
Washington University School of Medicine4
Weill Medical College of Cornell University4
GlaxoSmithKline3
Pulmonx Corporation3
Aarhus University Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Emphysema117
Pulmonary Disease, Chronic Obstructive92
Bronchitis, Chronic27
Lung Diseases11
Asthma10
Bronchitis9
alpha 1-Antitrypsin Deficiency8
Lung Neoplasms7
HIV Infections6
Lung Diseases, Obstructive5

Trials

Showing 76 to 100 of 117. Each trial links to its page on Pharma Observatory.

17 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.